Anti-Obesity Drugs Market, 2016 - 2022 1 Cliquez pour lire
  • Commentaires

Anti-Obesity Drugs Market, 2016 - 2022

1

Publié sur dans “Science, Science”, langue – English. 4 pages.
Global anti-obesity drugs market segmented by approved drugs: buproprion and naltrexone (Contrave), orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), and liraglutide (Saxenda). Plus
S'abonner GRATUITEMENT